Article
HOXB13 promotes ovarian cancer progression
17 Oct 2007
Abstract excerpt
Deregulated expression of HOXB13 in a subset of estrogen receptor-positive breast cancer patients treated with tamoxifen monotherapy is associated with an aggressive clinical course and poor outcome. Because the ovary is another hormone-responsive organ, we investigated whether HOXB13 plays a role in ovarian cancer progression. We show that HOXB13 is expressed in multiple human ovarian cancer cell lines and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
